New York Life Investment Management’s Repligen RGEN Stock Holding History

New York Life Investment Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$984K	Buy	7,209 +581	+9%	+$71.4K	0.01%	692
2026 Q1	$781K	Buy	6,628 +1,978	+43%	+$276K	0.01%	712
2025 Q4	$762K	Sell	4,650 -680	-13%	-$107K	0.01%	662
2025 Q3	$712K	Sell	5,330 -172	-3%	-$20.9K	0.01%	719
2025 Q2	$684K	Sell	5,502 -113	-2%	-$14.4K	0.01%	712
2025 Q1	$714K	Buy	5,615 +53	+1%	+$8.16K	0.01%	712
2024 Q4	$801K	Sell	5,562 -455	-8%	-$65.2K	0.01%	706
2024 Q3	$895K	Sell	6,017 -345	-5%	-$49.5K	0.01%	720
2024 Q2	$802K	Buy	6,362 +612	+11%	+$95.9K	0.01%	728
2024 Q1	$1.06M	Sell	5,750 -154	-3%	-$29.3K	0.01%	660
2023 Q4	$1.06M	Buy	5,904 +375	+7%	+$58.4K	0.01%	647
2023 Q3	$879K	Buy	5,529 +2,958	+115%	+$484K	0.01%	649
2023 Q2	$364K	Buy	+2,571	New	+$412K	﹤0.01%	1129

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

New York Life Investment Management's RGEN Position: Q2 2026 in Review

New York Life Investment Management increased its Repligen (RGEN) stake by 8.8% in Q2 2026, buying an estimated $71.4K and bringing the position to 7,209 shares worth $984K. The position accounts for 0.01% of the portfolio, ranked #692.

New York Life Investment Management first reported a position in RGEN in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.06M in Q4 2023. 297 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

New York Life Investment Management held 7,209 shares of Repligen worth $984K as of Q2 2026.
New York Life Investment Management bought 581 Repligen shares in Q2 2026, an estimated $71.4K.
Repligen made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #692 holding.
New York Life Investment Management first reported a position in Repligen in Q2 2023 and has held it in 13 quarters since.
New York Life Investment Management's Repligen position peaked at $1.06M in Q4 2023.
297 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.